Non-opioid Analgesic Patch Market Report – Research, Industry Analysis Reports and Market Demands

Global Non-opioid Analgesic Patch Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report

Buy now

Table of Content

1 Market Overview

1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Product
- 1.3.1 Overview: Global Non-opioid Analgesic Patch Consumption Value by Product: 2021 Versus 2025 Versus 2032
- 1.3.2 Lidocaine Patch
- 1.3.3 Diclofenac Patch
- 1.3.4 Methyl Salicylate Patch
- 1.3.5 Flurbiprofen Patch
- 1.3.6 Loxoprofen Sodium Patch
- 1.3.7 Ketoprofen Patch
- 1.3.8 Capsaicin Patch
- 1.3.9 Others
1.4 Market Analysis by Type
- 1.4.1 Overview: Global Non-opioid Analgesic Patch Consumption Value by Type: 2021 Versus 2025 Versus 2032
- 1.4.2 Rx Channel
- 1.4.3 OTC Channel
1.5 Market Analysis by Application
- 1.5.1 Overview: Global Non-opioid Analgesic Patch Consumption Value by Application: 2021 Versus 2025 Versus 2032
- 1.5.2 Hospitals and Clinics
- 1.5.3 Retail Pharmacy
- 1.5.4 Online Pharmacy
1.6 Global Non-opioid Analgesic Patch Market Size & Forecast
- 1.6.1 Global Non-opioid Analgesic Patch Consumption Value (2021 & 2025 & 2032)
- 1.6.2 Global Non-opioid Analgesic Patch Sales Quantity (2021-2032)
- 1.6.3 Global Non-opioid Analgesic Patch Average Price (2021-2032)

2 Manufacturers Profiles

3 Competitive Environment: Non-opioid Analgesic Patch by Manufacturer

3.1 Global Non-opioid Analgesic Patch Sales Quantity by Manufacturer (2021-2026)
3.2 Global Non-opioid Analgesic Patch Revenue by Manufacturer (2021-2026)
3.3 Global Non-opioid Analgesic Patch Average Price by Manufacturer (2021-2026)
3.4 Market Share Analysis (2025)
- 3.4.1 Producer Shipments of Non-opioid Analgesic Patch by Manufacturer Revenue ($MM) and Market Share (%): 2025
- 3.4.2 Top 3 Non-opioid Analgesic Patch Manufacturer Market Share in 2025
- 3.4.3 Top 6 Non-opioid Analgesic Patch Manufacturer Market Share in 2025
3.5 Non-opioid Analgesic Patch Market: Overall Company Footprint Analysis
- 3.5.1 Non-opioid Analgesic Patch Market: Region Footprint
- 3.5.2 Non-opioid Analgesic Patch Market: Company Product Type Footprint
- 3.5.3 Non-opioid Analgesic Patch Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

4.1 Global Non-opioid Analgesic Patch Market Size by Region
- 4.1.1 Global Non-opioid Analgesic Patch Sales Quantity by Region (2021-2032)
- 4.1.2 Global Non-opioid Analgesic Patch Consumption Value by Region (2021-2032)
- 4.1.3 Global Non-opioid Analgesic Patch Average Price by Region (2021-2032)
4.2 North America Non-opioid Analgesic Patch Consumption Value (2021-2032)
4.3 Europe Non-opioid Analgesic Patch Consumption Value (2021-2032)
4.4 Asia-Pacific Non-opioid Analgesic Patch Consumption Value (2021-2032)
4.5 South America Non-opioid Analgesic Patch Consumption Value (2021-2032)
4.6 Middle East & Africa Non-opioid Analgesic Patch Consumption Value (2021-2032)

5 Market Segment by Product

5.1 Global Non-opioid Analgesic Patch Sales Quantity by Product (2021-2032)
5.2 Global Non-opioid Analgesic Patch Consumption Value by Product (2021-2032)
5.3 Global Non-opioid Analgesic Patch Average Price by Product (2021-2032)

6 Market Segment by Application

6.1 Global Non-opioid Analgesic Patch Sales Quantity by Application (2021-2032)
6.2 Global Non-opioid Analgesic Patch Consumption Value by Application (2021-2032)
6.3 Global Non-opioid Analgesic Patch Average Price by Application (2021-2032)

7 North America

7.1 North America Non-opioid Analgesic Patch Sales Quantity by Product (2021-2032)
7.2 North America Non-opioid Analgesic Patch Sales Quantity by Application (2021-2032)
7.3 North America Non-opioid Analgesic Patch Market Size by Country
- 7.3.1 North America Non-opioid Analgesic Patch Sales Quantity by Country (2021-2032)
- 7.3.2 North America Non-opioid Analgesic Patch Consumption Value by Country (2021-2032)
- 7.3.3 United States Market Size and Forecast (2021-2032)
- 7.3.4 Canada Market Size and Forecast (2021-2032)
- 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

8.1 Europe Non-opioid Analgesic Patch Sales Quantity by Product (2021-2032)
8.2 Europe Non-opioid Analgesic Patch Sales Quantity by Application (2021-2032)
8.3 Europe Non-opioid Analgesic Patch Market Size by Country
- 8.3.1 Europe Non-opioid Analgesic Patch Sales Quantity by Country (2021-2032)
- 8.3.2 Europe Non-opioid Analgesic Patch Consumption Value by Country (2021-2032)
- 8.3.3 Germany Market Size and Forecast (2021-2032)
- 8.3.4 France Market Size and Forecast (2021-2032)
- 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
- 8.3.6 Russia Market Size and Forecast (2021-2032)
- 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

9.1 Asia-Pacific Non-opioid Analgesic Patch Sales Quantity by Product (2021-2032)
9.2 Asia-Pacific Non-opioid Analgesic Patch Sales Quantity by Application (2021-2032)
9.3 Asia-Pacific Non-opioid Analgesic Patch Market Size by Region
- 9.3.1 Asia-Pacific Non-opioid Analgesic Patch Sales Quantity by Region (2021-2032)
- 9.3.2 Asia-Pacific Non-opioid Analgesic Patch Consumption Value by Region (2021-2032)
- 9.3.3 China Market Size and Forecast (2021-2032)
- 9.3.4 Japan Market Size and Forecast (2021-2032)
- 9.3.5 South Korea Market Size and Forecast (2021-2032)
- 9.3.6 India Market Size and Forecast (2021-2032)
- 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
- 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

10.1 South America Non-opioid Analgesic Patch Sales Quantity by Product (2021-2032)
10.2 South America Non-opioid Analgesic Patch Sales Quantity by Application (2021-2032)
10.3 South America Non-opioid Analgesic Patch Market Size by Country
- 10.3.1 South America Non-opioid Analgesic Patch Sales Quantity by Country (2021-2032)
- 10.3.2 South America Non-opioid Analgesic Patch Consumption Value by Country (2021-2032)
- 10.3.3 Brazil Market Size and Forecast (2021-2032)
- 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

11.1 Middle East & Africa Non-opioid Analgesic Patch Sales Quantity by Product (2021-2032)
11.2 Middle East & Africa Non-opioid Analgesic Patch Sales Quantity by Application (2021-2032)
11.3 Middle East & Africa Non-opioid Analgesic Patch Market Size by Country
- 11.3.1 Middle East & Africa Non-opioid Analgesic Patch Sales Quantity by Country (2021-2032)
- 11.3.2 Middle East & Africa Non-opioid Analgesic Patch Consumption Value by Country (2021-2032)
- 11.3.3 Turkey Market Size and Forecast (2021-2032)
- 11.3.4 Egypt Market Size and Forecast (2021-2032)
- 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
- 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

12.1 Non-opioid Analgesic Patch Market Drivers
12.2 Non-opioid Analgesic Patch Market Restraints
12.3 Non-opioid Analgesic Patch Trends Analysis
12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

13.1 Raw Material of Non-opioid Analgesic Patch and Key Manufacturers
13.2 Manufacturing Costs Percentage of Non-opioid Analgesic Patch
13.3 Non-opioid Analgesic Patch Production Process
13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
14.2 Non-opioid Analgesic Patch Typical Distributors
14.3 Non-opioid Analgesic Patch Typical Customers

15 Research Findings and Conclusion

16 Appendix

16.1 Methodology
16.2 Research Process and Data Source

Description

According to our (Global Info Research) latest study, the global Non-opioid Analgesic Patch market size was valued at US$ 3655 million in 2025 and is forecast to a readjusted size of US$ 4907 million by 2032 with a CAGR of 4.3% during review period.
A non-opioid analgesic patch is a transdermal delivery system that administers pain-relieving medication directly through the skin without using opioids. It typically contains non-narcotic agents such as non-steroidal anti-inflammatory drugs (NSAIDs) or other alternative analgesics, which provide targeted, sustained relief for localized pain conditions. By releasing the active ingredient steadily over several hours, these patches help maintain consistent therapeutic levels at the site of pain, reducing the need for frequent dosing and minimizing systemic side effects. This method of pain management offers an effective and safer alternative to opioid-based treatments, lowering the risk of dependency and adverse reactions while improving patient compliance and comfort.
The global Non-opioid Analgesic Patch market is experiencing steady growth, driven by the increasing demand for safer and non-addictive pain management solutions. Rising awareness of the risks associated with opioid medications, particularly the opioid crisis in North America, has accelerated the shift toward alternative pain relief options. These patches, typically containing NSAIDs (e.g., diclofenac or ketoprofen), lidocaine, or herbal actives, are gaining popularity due to their targeted delivery, minimal systemic exposure, and ease of use.
In terms of market structure, the global non-opioid analgesic patch market is dominated by a few multinational pharmaceutical companies along with several regional players. Hisamitsu Pharmaceutical of Japan is a benchmark enterprise globally for transdermal analgesic products, while Lead Chemical and Teikoku Seiyaku hold core competitiveness in patch manufacturing and international supply. In Europe and North America, the market is led by brands such as Haleon, IBSA, Grünenthal (Averitas), and Kenvue, along with generic drug manufacturers like Teva and Viatris. In China, domestic companies such as Lingrui Pharmaceutical, Yunnan Baiyao, Jiudian Pharmaceutical, and Tide Pharmaceutical have secured certain market shares through broad distribution networks and inclusion in national reimbursement lists. Going forward, as non-opioid pain management policies evolve and transdermal technologies continue to advance, the global market is expected to see further consolidation.
This report is a detailed and comprehensive analysis for global Non-opioid Analgesic Patch market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Product and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Non-opioid Analgesic Patch market size and forecasts, in consumption value ($ Million), sales quantity (M Pcs), and average selling prices (US$/Pcs), 2021-2032
Global Non-opioid Analgesic Patch market size and forecasts by region and country, in consumption value ($ Million), sales quantity (M Pcs), and average selling prices (US$/Pcs), 2021-2032
Global Non-opioid Analgesic Patch market size and forecasts, by Product and by Application, in consumption value ($ Million), sales quantity (M Pcs), and average selling prices (US$/Pcs), 2021-2032
Global Non-opioid Analgesic Patch market shares of main players, shipments in revenue ($ Million), sales quantity (M Pcs), and ASP (US$/Pcs), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Non-opioid Analgesic Patch
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Non-opioid Analgesic Patch market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Hisamitsu Pharmaceutical, Teikoku Seiyaku, IBSA Pharma, Kowa Company, Haleon, Kenvue, Opella Healthcare, Viatris, Teva Pharmaceuticals, Lead Chemical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Non-opioid Analgesic Patch market is split by Product and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Product, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Product
Lidocaine Patch
Diclofenac Patch
Methyl Salicylate Patch
Flurbiprofen Patch
Loxoprofen Sodium Patch
Ketoprofen Patch
Capsaicin Patch
Others
Market segment by Type
Rx Channel
OTC Channel
Market segment by Application
Hospitals and Clinics
Retail Pharmacy
Online Pharmacy
Major players covered
Hisamitsu Pharmaceutical
Teikoku Seiyaku
IBSA Pharma
Kowa Company
Haleon
Kenvue
Opella Healthcare
Viatris
Teva Pharmaceuticals
Lead Chemical
Mikasa Seiyaku
Averitas Pharma
Sparsha Pharma
TEH SENG Pharmaceutical
Anhui Fengyuan Pharmaceutical
Beijing Tide Pharmaceutical
Jiudian Pharmaceutical
Yunnan Baiyao
Lingrui Pharmaceutical
Anhui Jinma Pharmaceutical
Guizhou Liansheng Pharmaceutical
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Non-opioid Analgesic Patch product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Non-opioid Analgesic Patch, with price, sales quantity, revenue, and global market share of Non-opioid Analgesic Patch from 2021 to 2026.
Chapter 3, the Non-opioid Analgesic Patch competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Non-opioid Analgesic Patch breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Product and by Application, with sales market share and growth rate by Product, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Non-opioid Analgesic Patch market forecast, by regions, by Product, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Non-opioid Analgesic Patch.
Chapter 14 and 15, to describe Non-opioid Analgesic Patch sales channel, distributors, customers, research findings and conclusion.

Buy now